AARTHEx Biotech — Seed · €2.7M
Arthex Biotech is a University of Valencia spin-off developing antisense RNA therapies, starting with myotonic dystrophy type 1. It secured €2.7M: €1.5M from Invivo Ventures and €1.2M from CDTI through Innvierte. Later in July the round was reported at a €4.25M total.
LeadInvivo Ventures
RoundSeed
Announced8 Jan 2020
CityValencia
SectorHealthtech & Bio · Biotech
Source
C
C
